ArticleBMJ open2021

Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial.

Kam Wa Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.